ChemRar Ventures
Overview
ChemRar Ventures is a Russian venture capital firm specializing in investments within the pharmaceutical and biotechnology sectors. The firm is part of the ChemRar Group, a conglomerate that unites research, manufacturing, and investment companies dedicated to the development and commercialization of innovative medicines, diagnostics, and treatments for life-threatening diseases both in Russia and internationally. ChemRar Ventures manages a diversified portfolio of investments in innovative biotechnological and biopharmaceutical companies, aiming to advance healthcare solutions and improve patient outcomes. The firm's investment strategy encompasses various stages of company development, including seed, early stage, Series A, Series B, growth, late stage, and pre-IPO rounds. ChemRar Ventures focuses on a wide geographical area, with investments spanning Russia, the United States, the European Union, China, India, Brazil, Japan, South Korea, Canada, Australia, Mexico, South Africa, Turkey, Saudi Arabia, Argentina, the United Kingdom, France, Germany, Italy, and Spain. This broad geographical focus allows the firm to tap into diverse markets and identify promising opportunities in the global pharmaceutical and biotechnology landscape. ChemRar Ventures has a history of active involvement in the development of antiviral drugs, notably collaborating with the Russian Direct Investment Fund (RDIF) to produce Avifavir, the first favipiravir-based drug approved for the treatment of COVID-19. This partnership underscores the firm's commitment to addressing global health challenges through innovative pharmaceutical solutions. By leveraging its extensive network and expertise, ChemRar Ventures continues to support the growth and success of its portfolio companies, contributing to advancements in medical treatments and therapies worldwide.
Investment Focus
- Innovative biotechnological and biopharmaceutical companies
- Companies in seed to pre-IPO stages
- Companies operating in Russia and internationally
Portfolio Companies
Reach ChemRar Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about ChemRar Ventures
What sectors does ChemRar Ventures invest in?
ChemRar Ventures invests in Technology, Healthcare, Energy, Consumer Goods, Real Estate and Materials, and is based in Moscow Region, Russia. ChemRar Ventures is listed as a venture capital in the ConnectSafely investor database.
What stage does ChemRar Ventures invest at?
ChemRar Ventures backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does ChemRar Ventures invest in?
ChemRar Ventures invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has ChemRar Ventures invested in?
ChemRar Ventures's portfolio includes Aviron, Viriom, Avineuro, CardioSystemPharma, NewVac and Chromis.
Last updated · Source: ConnectSafely investor database
